Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
JournalThe Lancet Haematology
DOIs
StateAccepted/In press - Jan 1 2017

Fingerprint

eltrombopag

ASJC Scopus subject areas

  • Hematology

Cite this

@article{ecda81a5eb1b4a73a737e94001794740,
title = "Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML",
author = "Aditi Shastri and Verma, {Amit K.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/S2352-3026(17)30229-6",
language = "English (US)",
journal = "The Lancet Haematology",
issn = "2352-3026",
publisher = "Lancet Publishing Group",

}

TY - JOUR

T1 - Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML

AU - Shastri, Aditi

AU - Verma, Amit K.

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=85037733772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037733772&partnerID=8YFLogxK

U2 - 10.1016/S2352-3026(17)30229-6

DO - 10.1016/S2352-3026(17)30229-6

M3 - Article

JO - The Lancet Haematology

JF - The Lancet Haematology

SN - 2352-3026

ER -